For help on how to get the results you want, see our search tips.
289 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 14/11/2019,
, Revision: 1, Authorised, Last updated: 01/07/2020
-
List item
Human medicine European public assessment report (EPAR): Soliris (updated)
Eculizumab, Hemoglobinuria, Paroxysmal
Date of authorisation: 20/06/2007,
, 
, Revision: 29, Authorised, Last updated: 01/07/2020
-
List item
Human medicine European public assessment report (EPAR): Capecitabine Teva (updated)
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012,
, , Revision: 12, Authorised, Last updated: 29/06/2020
-
List item
Human medicine European public assessment report (EPAR): Pregabalin Sandoz (updated)
pregabalin, Anxiety Disorders, Neuralgia, Epilepsy
Date of authorisation: 19/06/2015,, Revision: 4, Authorised, Last updated: 26/06/2020
-
List item
Human medicine European public assessment report (EPAR): Pregabalin Sandoz GmbH (updated)
pregabalin, Anxiety Disorders, Epilepsy
Date of authorisation: 19/06/2015,, Revision: 5, Authorised, Last updated: 25/06/2020
-
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva (updated)
lamivudine, Hepatitis B, Chronic
Date of authorisation: 23/10/2009,, Revision: 9, Authorised, Last updated: 24/06/2020
-
List item
Human medicine European public assessment report (EPAR): Deferasirox Mylan (updated)
deferasirox, Iron Overload, beta-Thalassemia
Date of authorisation: 26/09/2019,, Authorised, Last updated: 24/06/2020
-
List item
Human medicine European public assessment report (EPAR): Pazenir (updated)
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,, Revision: 5, Authorised, Last updated: 24/06/2020
-
List item
Human medicine European public assessment report (EPAR): Zoledronic acid medac (updated)
zoledronic acid monohydrate, Fractures, Bone, Cancer
Date of authorisation: 03/08/2012,, Revision: 12, Authorised, Last updated: 24/06/2020
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 30/06/2015,, Revision: 10, Authorised, Last updated: 24/06/2020
-
List item
Human medicine European public assessment report (EPAR): Carmustine Obvius (updated)
carmustine, Hodgkin Disease, Lymphoma, Non-Hodgkin
Date of authorisation: 18/07/2018,, Revision: 4, Authorised, Last updated: 23/06/2020
-
List item
Human medicine European public assessment report (EPAR): Kalydeco (updated)
ivacaftor, Cystic Fibrosis
Date of authorisation: 22/07/2012,, , Revision: 23, Authorised, Last updated: 22/06/2020
-
List item
Human medicine European public assessment report (EPAR): Maviret (updated)
glecaprevir / pibrentasvir, Hepatitis C, Chronic
Date of authorisation: 26/07/2017,
, , Revision: 10, Authorised, Last updated: 22/06/2020
-
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva Pharma B.V. (updated)
lamivudine, HIV Infections
Date of authorisation: 10/12/2009,, Revision: 15, Authorised, Last updated: 19/06/2020
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Zentiva (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 25/06/2015,, Revision: 7, Authorised, Last updated: 17/06/2020
-
List item
Human medicine European public assessment report (EPAR): Miglustat Gen.Orph (updated)
miglustat, Gaucher Disease
Date of authorisation: 09/11/2017,, Revision: 6, Authorised, Last updated: 17/06/2020
-
List item
Human medicine European public assessment report (EPAR): Pemetrexed Lilly (updated)
pemetrexed, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 14/09/2015,, Revision: 5, Authorised, Last updated: 16/06/2020
-
List item
Human medicine European public assessment report (EPAR): Olazax Disperzi (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 10/12/2009,, Revision: 12, Authorised, Last updated: 16/06/2020
-
List item
Human medicine European public assessment report (EPAR): Kyprolis (updated)
carfilzomib, Multiple Myeloma
Date of authorisation: 19/11/2015,, , , Revision: 16, Authorised, Last updated: 16/06/2020
-
List item
Human medicine European public assessment report (EPAR): Cabometyx (updated)
cabozantinib s-malate, Carcinoma, Renal Cell
Date of authorisation: 09/09/2016,, , Revision: 8, Authorised, Last updated: 15/06/2020
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva (updated)
efavirenz, emtricitabine, tenofovir disoproxil, phosphate, HIV Infections
Date of authorisation: 17/07/2017,, Revision: 5, Authorised, Last updated: 15/06/2020
-
List item
Human medicine European public assessment report (EPAR): Mysildecard (updated)
sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 15/09/2016,, Revision: 2, Authorised, Last updated: 15/06/2020
-
List item
Human medicine European public assessment report (EPAR): Brineura (updated)
cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017,, , , 
, Revision: 4, Authorised, Last updated: 12/06/2020
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan (updated)
emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 16/12/2016,, Revision: 6, Authorised, Last updated: 11/06/2020
-
List item
Human medicine European public assessment report (EPAR): Pregabalin Zentiva (updated)
pregabalin, Anxiety Disorders, Epilepsy
Date of authorisation: 17/07/2015,, Revision: 7, Authorised, Last updated: 10/06/2020